NCT00743860View on ClinicalTrials.gov

A Healthy Volunteer Pharmacokinetic Study of Single and Repeat Doses of SB-480848

PHASE1CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions

Atherosclerosis

Interventions

DRUG

darapladib

experimental drug

Trial Locations (1)

98418

GSK Investigational Site, Tacoma

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT00743860 - A Healthy Volunteer Pharmacokinetic Study of Single and Repeat Doses of SB-480848 | Biotech Hunter | Biotech Hunter